Carregant...
The dark side of PD-1 receptor inhibition
Inhibiting the protein PD-1 can activate T cells that trigger immune responses against tumour cells. But it emerges that, in mice, this immunotherapy exacerbates a cancer that involves the T cells themselves.
Guardat en:
| Publicat a: | Nature |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136420/ https://ncbi.nlm.nih.gov/pubmed/29143822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature24759 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|